The molecular biology of peritoneal carcinomatosis from gastrointestinal cancer

Annals of the Academy of Medicine Singapore

Volumn 32, Issue 2, 2003, Pages 219-225

  Jayne, David G ^a,b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Gastrointestinal neoplasms; Neoplasm metastasis; Peritoneum

Indexed keywords

BETA1 INTEGRIN; CELL ADHESION MOLECULE; CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HERMES ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MATRILYSIN; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PROSTACYCLIN; PROSTAGLANDIN E2; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; CANCER INVASION; CARCINOMATOUS PERITONITIS; CELL ADHESION; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; HUMAN; LYMPHOKINE ACTIVATED KILLER CELL; MEDLINE; MESOTHELIUM; MOLECULAR BIOLOGY; REVIEW; SCANNING ELECTRON MICROSCOPY; SURVIVAL TIME;

EID: 0037482849     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Sampson J A. Implantation peritoneal carcinomatosis of ovarian origin. Am J Pathol 1931; 7:423-43.
2. Aranha G V, Folk F A, Greenlee H B. Surgical palliation of small bowel obstruction due to metastatic carcinoma. Am Surg 1981; 47:99-102.
3. Spratt J S, Edwards M, Kubota T, Lindberg R, Tseng M T. Peritoneal carcinomatosis: anatomy, physiology, diagnosis, management. Curr Prob Cancer 1986; 10:558-84.
4. Sugarbaker P H, Schellinx M E, Chang D, Koslowe P, von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996; 20:585-92.
5. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999; 85:529-34.
6. Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92:71-6.
7. Witkamp A J, de Bree E, Kaag M M, Boot H, Beijnen J H, van Slooten G W, et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001; 37:979-84.
8. Yu W, Whang I, Chung H Y, Averbach A, Sugarbaker P H. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg 2001; 25:985-90.
9. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; 1:571-3.
10. Tarply J L, Tworney P L, Catalona W J, Chretien P B. Suppression of cellular immunity by anaesthesia and operation. J Surg Res 1997; 22:195-201.
11. Takekoshi T, Sakata K, Kunieda T, Saji S, Tanemura H, Yamamoto S. Facilitation of tumor metastasis by operative stress and participation of cell-mediated immunity. Experimental study. Oncology 1984; 41: 245-51.
12. Klava A, Windsor A C, Farmery S M, Woodhouse L F, Reynolds J V, Ramsden C W, et al. Interleukin-10. A role in the development of postoperative immunosuppression. Arch Surg 1997; 132:425-9.
13. Eggermont A M, Steller E P, Marquet R L, Jeekel J, Sugarbaker P H. Local regional promotion of tumor growth after abdominal surgery is dominant over immunotherapy with interleukin-2 and lymphokine activated killer cells. Cancer Detect Prev 1988; 12:421-9.
14. van den Tol P M, van Rossen E E, van Eijck C H, Bonthuis F, Marquet R L, Jeekel J. Reduction of peritoneal trauma by using nonsurgical gauze leads to less implantation metastasis of spilled tumor cells. Ann Surg 1998; 227:242-8.
15. Mathew G, Watson D I, Rofe A M, Baigrie C F, Ellis T, Jamieson G G. Wound metastases following laparoscopic and open surgery for abdominal cancer in a rat model. Br J Surg 1996; 83:1087-90.
16. Allardyce R A, Morreau P N, Frizelle F A, Bagshaw P F. Tumour cell wound distribution after colectomy in a porcine model. Aust N Z J Surg 1998; 68:363-6.
17. 2 pneumoperitoneum: a rat ovarian cancer model. Obstet Gynecol 1998; 92:104-8.
18. Gutt C N, Riemer V, Kim Z G, Jacobi C A, Paolucci V, Lorenz M. Impact of laparoscopic colonic resection on tumour growth and spread in an experimental model. Br J Surg 1999; 86:1180-4.
19. Tsukada K, Katoh H, Shiojima M, Suzuki T, Takenoshita S, Nagamachi Y. Concentrations of cytokines in peritoneal fluid after abdominal surgery. Eur J Surg 1993; 159:475-9.
20. Badia J M, Whawell S A, Scott-Coombes D M, Abel P D, Williamson R C, Thompson J N. Peritoneal and systemic cytokine response to laparotomy. Br J Surg 1996; 83:347-8.
21. Topley N. The cytokine network controlling peritoneal inflammation. Perit Dial Int 1995; 15:S35-40.
22. Topley N, Jorres A, Luttmann W, Petersen M M, Lang M J, Thierauch K H, et al. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int 1993; 43:226-33.
23. Topley N, Brown Z, Jorres A, Westwick J, Davies M, Coles G A, et al. Human peritoneal mesothelial cells synthesize interleukin-8: Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J Pathol 1993; 142:1876-86.
24. Kinnaert P, De Wilde J P, Bournonville B, Husson C, Salmon I. Direct activation of human peritoneal mesothelial cells by heat-killed microorganisms. Ann Surg 1996; 224:749-55.
25. Topley N, Petersen M M, Mackenzie R, Neubauer A, Stylianou E, Kaever V, et al. Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage-derived cytokines. Kidney Int 1994; 46:900-9.
26. Jorres A, Ludat K, Lang J, Sander K, Gahl G M, Frei U, et al. Establishment and functional characterization of human peritoneal fibroblasts in culture: regulation of interleukin-6 production by proinflammatory cytokines. J Am Soc Nephrol 1996; 7:2192-201.
27. Jorres A. Effect of peritoneal dialysis on peritoneal cell biology: peritoneal fibroblasts. Perit Dial Int 1999; 19(Suppl 2):S348-52.
28. Beavis M J, Williams J D, Hoppe J, Topley N. Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 1997; 51:205-15.
29. Fukasawa M, Yanagihara D L, Rodgers K E, DiZerega G S. The mitogenic activity of peritoneal tissue repair cells: control by growth factors. J Surg Res 1989; 47:45-51.
30. Fukasawa M, Campeau J D, Yanagihara D L, Rodgers K E, DiZerega G S. Regulation of proliferation of peritoneal tissue repair cells by peritoneal macrophages. J Surg Res 1990; 49:81-7.
31. Chegini N. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta). Eur J Surg Suppl 1997; 577:17-23.
32. Iwamoto I, Imada A. Effects of growth factors on proliferation of culture human peritoneal mesothelial cells [Japanese[. Nippon Jinzo Gakkai Shi 1992; 34:1201-8.
33. Leavesley D I, Stanley J M, Faull R J. Epidermal growth factor modifies the expression and function of extracellular matrix adhesion receptors expressed by peritoneal mesothelial cells from patients on CAPD. Nephrol Dial Transplant 1999; 14:1208-16.
34. Jayne D G, Perry S L, Morrison E, Farmery S M, Guillou P J. Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases. Br J Cancer 2000; 82:1233-8.
35. Sato M, Narita T, Kawakami-Kimura N, Higashiyama S, Taniguchi N, Akiyama S, et al. Increased expression of integrins by heparin-binding EGF-like growth factor in human esophageal cancer cells. Cancer Lett 1996; 102:183-91.
36. Narita T, Kawakami-Kimura N, Sato M, Matsuura N, Higashiyama S, Taniguchi N, et al. Alteration of integrins by heparin-binding EGF-like growth factor in human breast cancer cells. Oncology 1996; 53:374-81.
37. Melder R J, Koenig G C, Witwer B P, Safabakhsh N, Munn L L, Jain R K. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 1996; 2:992-7.
38. Naef M, Yokoyama M, Friess H, Buchler M W, Korc M. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. Int J Cancer 1996; 66:315-21.
39. Kobrin M S, Funatomi H, Friess H, Buchler M W, Stathis P, Korc M. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1994; 202:1705-9.
40. Dignass A U, Tsunekawa S, Podolsky D K. Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 1994; 106:1254-62.
41. Ushiro S, Ono M, Izumi H, Kohno K, Taniguchi N, Higashiyama S, et al. Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells. Jpn J Cancer Res 1996; 87:68-77.
42. Rofstad E K, Halsor E F. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res 2000; 60:4932-8.
43. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64:867-9.
44. Coltrini D, Rusnati M, Zoppetti G, Oreste P, Grazioli G, Naggi A, et al. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. Biochem J 1994; 303:583-90.
45. Engelberg H. Actions of heparin that may affect the malignant process. Cancer 1999; 85:257-72.
46. Goldstein D S, Lu M L, Hattori T, Ratliff T L, Loughlin K R, Kavoussi L R. Inhibition of peritoneal tumour-cell implantation: model for laparoscopic cancer surgery. J Endourol 1993; 7:237-41.
47. Jacobi C A, Ordemann J, Bohm B, Zieren H U, Sabat R, Muller J M. Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. Am J Surg 1997; 174:359-63.
48. Neuhaus S J, Ellis T, Jamieson G G, Watson D I. Experimental study of the effect of intraperitoneal heparin on tumour implantation following laparoscopy. Br J Surg 1999; 86:400-4.
49. Jayson G C, Gallagher J T. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells. Br J Cancer 1997; 75:9-16.
50. Vlodavsky I, Mohsen M, Lider O, Svahn C M, Ekre H P, Vigoda M, et al. Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Invasion Metastasis 1994; 14:290-302.
51. Lapierre F, Holme K, Lam L, Tressler R J, Storm N, Wee J, et al. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology 1996; 6:355-66.
52. Yonemura Y, Nojima N, Kaji M, Fujimura T, Itoh H, Ninomiya I, et al. E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer 1995; 76:941-53.
53. Wisbeck W M, Becher E M, Russell A H. Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol 1986; 7:13-8.
54. Kaibara N, Iitsuka Y, Kimura A, Kobayashi Y, Hirooka Y, Nishidoi H, et al. Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma. Cancer 1987; 60:136-9.
55. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 1997; 21: 195-200.
56. Shepherd N A, Baxter K J, Love S B. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 1997; 112:1096-102.
57. Zirngibl H, Husemann B, Hermanek P. Intraoperative spillage of tumor cells in surgery for rectal cancer. Dis Colon Rectum 1990; 33:610-4.
58. Ranbarger K R, Johnston W D, Chang J C. Prognostic significance of surgical perforation of the rectum during abdominoperineal resection for rectal carcinoma. Am J Surg 1982; 143:186-8.
59. Slanetz C A Jr. The effect of inadvertent intraoperative perforation on survival and recurrence in colorectal cancer. Dis Colon Rectum 1984; 27:792-7.
60. Skipper D, Cooper A J, Marston J E, Taylor I. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987; 74:1049-52.
61. Leather A J, Kocjan G, Savage F, Hu W, Yiu C Y, Boulos P B, et al. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum 1994; 37:814-9.
62. Leach S D, Rose J A, Lowy A M, Lee J E, Charnsangavej C, Abbruzzese J L, et al. Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery 1995; 118:472-8.
63. Merchant N B, Conlon K C, Saigo P, Dougherty E, Brennan M F. Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma. J Am Coll Surg 1999; 188:421-6.
64. Vogel P, Ruschoff J, Kummel S, Zirngibl H, Hofstadter F, Hohenberger W, et al. Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer. Dis Colon Rectum 2000; 43:92-100.
65. Hayes N, Wayman J, Wadehra V, Scott D J, Raimes S A, Griffin S M. Peritoneal cytology in the surgical evaluation of gastric carcinoma. Br J Cancer 1999; 79:520-4.
66. Burke E C, Karpeh M S Jr, Conlon K C, Brennan M F. Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol 1998; 5:411-5.
67. Kotanagi H, Saito Y, Yoshioka T, Koyama K. Characteristics of two cancer cell lines derived from metastatic foci in liver and peritoneum of a patient with colon cancer. J Gastroenterol 1998; 33:842-9.
68. Yung S, Coles G A, Davies M. IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney Int 1996; 50:1337-43.
69. Schlaeppi M, Ruegg C, Tran-Thang C, Chapuis G, Tevaearai H, Lahm H, et al. Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix. Cell Adhes Commun 1997; 4:439-55.
70. Yonemura Y, Endou Y, Yamaguchi T, Nojima N, Kawamura T, Fujimura T, et al. Roles of VLA-2 and VLA-3 on the formation of peritoneal dissemination in gastric cancer. Int J Oncol 1996; 8:925-31.
71. Jayne D G, O'Leary R, Gill A, Hick A, Guillou P J. A three-dimensional in-vitro model for the study of peritoneal tumour metastasis. Clin Exp Metastasis 1999; 17:515-23.
72. Buck R C. Walker 256 tumor implantation in normal and injured peritoneum studied by electron microscopy, scanning electron microscopy, and autoradiography. Cancer Res 1973; 33:3181-8.
73. Akedo H, Shinkai K, Mukai M, Mori Y, Tateishi R, Tanaka K, et al. Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion. Cancer Res 1986; 46:2416-22.
74. Kiyasu Y, Kaneshima S, Koga S. Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res 1981; 41:1236-9.
75. Kimura A, Koga S, Kudoh H, Iitsuka Y. Peritoneal mesothelial cell injury factors in rat cancerous ascites. Cancer Res 1985; 45:4330-3.
76. Yonemura Y, Endou Y, Nojima N, Kawamura T, Fujita H, Kaji M, et al. A possible role of cytokines in the formation of peritoneal dissemination. Int J Oncol 1997; 11:349-58.
77. Heath R M, Jayne D G, O'Leary R, Guillou P J. Tumour-induced apoptosis: a novel mechanism of peritoneal invasion. Br J Surg 2000; 87(Suppl 1):14.
78. Yonemura Y, Endo Y, Fujita H, Kimura K, Sugiyama K, Momiyama N, et al. Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide. J Exp Clin Cancer Res 2001; 20:205-12.
79. Aparicio T, Kermorgant S, Dessirier V, Lewin M J, Lehy T. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Carcinogenesis 1999; 20:1445-51.
80. Li X, Nagayasu H, Hamada J, Hosokawa M, Takeichi N. Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-beta. Jpn J Cancer Res 1993; 84:1145-9.
81. Davies D E, Farmer S, White J, Senior P V, Warnes S L, Alexander P. Contribution of host-derived growth factors to in vivo growth of a transplantable murine mammary carcinoma. Br J Cancer 1994; 70: 263-9.
82. van der Wal B C, Hofland L J, Marquet R L, van Koetsveld P M, van Rossen M E, van Eijck C H. Paracrine interactions between mesothelial and colon-carcinoma cells in a rat model. Int J Cancer 1997; 73:885-90.